Adva Levy‐Barda - Concepedia

Author

Adva Levy‐Barda

Tel Aviv University ORCID

Also Known As

A Levy-Barda, A. Levy-Barda, Adva Levy-Barda, Adva Levy‐Barda

Publications

681

Citations

H-Index

Concepts

All Affiliations

Tel Aviv University Rabin Medical Center Sheba Medical Center Bar-Ilan University Hebrew University of Jerusalem

About

Adva Levy‐Barda is an author at Tel Aviv University specializing in molecular biology, natural sciences, and genome instability.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	136
2	Natural Sciences	3	3	136
3	Molecular Biology	3	3	136
4	Cell Biology	2	2	81
5	Molecular Medicine	1	1	66

Adva Levy‐Barda

Publications

613

Citations

H-Index

Page 1

	Year	Citations
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer Amir Massarweh, Noa Eliakim‐Raz, Amos Stemmer, JAMA Oncology	2021	282
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα Hadar Edelman-Klapper, Eran Zittan, Ariella Bar‐Gil Shitrit, Gastroenterology	2021	91
Involvement of the nuclear proteasome activator PA28γ in the cellular response to DNA double-strand breaks Adva Levy‐Barda, Yaniv Lerenthal, Anthony J. Davis, Cell Cycle ProteasomeMolecular BiologyDsb RepairCell CycleDouble-strand Breaks	2011	66
The Ubiquitin E3/E4 Ligase UBE4A Adjusts Protein Ubiquitylation and Accumulation at Sites of DNA Damage, Facilitating Double-Strand Break Repair Keren Baranes‐Bachar, Adva Levy‐Barda, Judith Oehler, Molecular Cell Genome InstabilityDouble-strand Break RepairDna DamageChromatin RemodelingNatural Sciences	2018	55
Detection of gene mutations and gene–gene fusions in circulating cell‐free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis Vikrant Palande, Tali Siegal, Rajesh Detroja, Molecular Oncology	2021	47
Unleashing Natural IL18 Activity Using an Anti-IL18BP Blocker Induces Potent Immune Stimulation and Antitumor Effects Assaf Menachem, Zoya Alteber, Gady Cojocaru, Cancer Immunology Research	2024	17
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer Noa Rabinowicz, Lingegowda S. Mangala, Kevin R. Brown, Oncotarget Genome InstabilityMedicineIncurable DiseaseNatural SciencesMolecular Biology	2017	15
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases Keren M. Rabinowitz, Michal Navon, Hadar Edelman-Klapper, Vaccines	2022	14
Altered somatic hypermutation patterns in COVID-19 patients classifies disease severity Modi Safra, Zvi Tamari, Pazit Polak, Frontiers in Immunology	2023	13
Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer Petros Christopoulos, Michal Harel, Kimberly McGregor, JCO Precision Oncology	2024	13

Page 1